Strattera and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Pulmicort (budesonide). Common drug interactions include dry skin among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Pulmicort. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

69 people who take Strattera and Pulmicort together, and have interactions are studied.

Strattera and Pulmicort drug interactions.

What are the common drug interactions of Strattera and Pulmicort, by gender? *:

female:

Dry skin
Dysphonia (speech disorder attributable to a disorder of phonation)
Eye discharge
Eye irritation
Flatulence (flatus expelled through the anus)
Hypersensitivity
Hypertrophic scar (skin condition characterized by deposits of excessive amounts of collagen which gives rise to a raised scar)
Immune system disorder
Joint stiffness
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)

male:

Fatigue (feeling of tiredness)
Pyrexia (fever)
Chest pain
Cough
Malaise (a feeling of general discomfort or uneasiness)
Mass
Purulent discharge (discharge that contains pus)
Headache (pain in head)
Injection site pain
Blood pressure decreased

What are the common drug interactions of Strattera and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Decreased appetite
Drug ineffective
Somnolence (a state of near-sleep, a strong desire for sleep)
Psychomotor hyperactivity (feelings of extreme restlessness)
Weight decreased
Abdominal pain upper
Abnormal behaviour
Appetite increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
Crying
Disturbance in attention

10-19:

Forced expiratory volume decreased (decreased lung expired air volume)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Heart rate increased
Influenza
Injection site pain
Lower respiratory tract infection
Myalgia (muscle pain)
Nasopharyngitis (inflammation of the nasopharynx)
Pain
Productive cough

20-29:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Pulmonary function test decreased
Back pain
Chest pain
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Nephrolithiasis (calculi in the kidneys)
Oropharyngeal pain
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Pneumonia

30-39:

Dizziness
Nausea (feeling of having an urge to vomit)
Asthenia (weakness)
Chest pain
Chills (felling of cold)
Crying
Difficulty in walking
Drug level increased
Emotional disorder
Fatigue (feeling of tiredness)

40-49:

Bladder neck suspension
Rectocele (a bulging of the front wall of the rectum into the back wall of the vagina)
Therapeutic response unexpected
Vulvovaginal pain

50-59:

Gastric disorder (disease of stomach)

60+:

Drug ineffective
Insomnia (sleeplessness)
Restless legs syndrome (a powerful urge to move your legs)
Somnolence (a state of near-sleep, a strong desire for sleep)

What are the existing conditions these people have? *

Stress And Anxiety: 8 people, 11.59%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 7.25%
Constipation: 5 people, 7.25%
Sinusitis (inflammation of sinus): 4 people, 5.80%
Rickets (softening of bones): 4 people, 5.80%
Insomnia (sleeplessness): 4 people, 5.80%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 4 people, 5.80%
Immunodeficiency Common Variable: 4 people, 5.80%
Immunodeficiency: 4 people, 5.80%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously